Hyun-Ki Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hyun-Ki Kim has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Sail Chun
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
6 shared publications - Woochang Lee
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan, College of Medicine , Seoul
6 shared publications - Won-Ki Min
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
5 shared publications M.D.
4 shared publications- Chan-Jeoung Park
Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
3 shared publications - Ji-Hun Lim
Department of Laboratory Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
3 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
History and Future of Efficient Design of Quality Control in Clinical Laboratories
Xincen Duan, Ph.D., Richard Pang, Ph.D., Sollip Kim, M.D., Ph.D., Hyun-Ki Kim, M.D., Ph.D., Yan Liu, Ph.D., Tze Ping Loh, M.B., B.Ch., B.A.O., Beili Wang, Ph.D., Qing H Meng, M.D., Ph.D., Tony Badrick, Ph.D., and Wei Guo, Ph.D., On behalf of the Patient-Based Real-Time Quality Control Working Group of the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0719
- 4 November 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
Open AccessHistory and Future of Efficient Design of Quality Control in Clinical Laboratories
Xincen Duan, Ph.D., Richard Pang, Ph.D., Sollip Kim, M.D., Ph.D., Hyun-Ki Kim, M.D., Ph.D., Yan Liu, Ph.D., Tze Ping Loh, M.B., B.Ch., B.A.O., Beili Wang, Ph.D., Qing H Meng, M.D., Ph.D., Tony Badrick, Ph.D., and Wei Guo, Ph.D., On behalf of the Patient-Based Real-Time Quality Control Working Group of the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0719
- 8 October 2024
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (10) , e0069924
Automated calculation and reporting of vancomycin area under the concentration–time curve: a simplified single-trough concentration-based equation approach
Vancomycin, a crucial antibiotic for Gram-positive bacterial infections, requires therapeutic drug monitoring (TDM). Contemporary guidelines advocate for AUC-based monitoring; however, using Bayesian programs for AUC estimation poses challenges. We aimed to develop and evaluate a simplified AUC estimation equation using a steady-state trough concentration (C trough ) value. Utilizing 1,034 TDM records from 580 general hospitalized patients at a university-affiliated hospital in Ulsan, we created an equation named SSTA that calculates the AUC by applying C trough , body weight, and single dose as input variables. External validation included 326 records from 163 patients at a university-affiliated hospital in Seoul (EWUSH) and literature data from 20 patients at a university-affiliated hospital in Bangkok (MUSI). It was compared with other AUC estimation models based on the C trough , including a linear regression model (LR), a sophisticated model based on the first-order equation (VancoPK), and a Bayesian model (BSCt). Evaluation metrics, such as median absolute percentage error (MdAPE) and the percentage of observations within ±20% error (P20), were calculated. External validation using the EWUSH data set showed that SSTA, LR, VancoPK, and BSCt had MdAPE values of 6.4, 10.1, 6.6, and 7.5% and P20 values of 87.1, 82.5, 87.7, and 83.4%, respectively. External validation using the MUSI data set showed that SSTA, LR, and VancoPK had MdAPEs of 5.2, 9.4, and 7.2%, and P20 of 95, 90, and 95%, respectively. Owing to its decent AUC prediction performance, simplicity, and convenience for automated calculation and reporting, SSTA could be used as an adjunctive tool for the AUC-based TDM.
- 8 October 2024
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (10) , e0069924
Automated calculation and reporting of vancomycin area under the concentration–time curve: a simplified single-trough concentration-based equation approach
Vancomycin, a crucial antibiotic for Gram-positive bacterial infections, requires therapeutic drug monitoring (TDM). Contemporary guidelines advocate for AUC-based monitoring; however, using Bayesian programs for AUC estimation poses challenges. We aimed to develop and evaluate a simplified AUC estimation equation using a steady-state trough concentration (C trough ) value. Utilizing 1,034 TDM records from 580 general hospitalized patients at a university-affiliated hospital in Ulsan, we created an equation named SSTA that calculates the AUC by applying C trough , body weight, and single dose as input variables. External validation included 326 records from 163 patients at a university-affiliated hospital in Seoul (EWUSH) and literature data from 20 patients at a university-affiliated hospital in Bangkok (MUSI). It was compared with other AUC estimation models based on the C trough , including a linear regression model (LR), a sophisticated model based on the first-order equation (VancoPK), and a Bayesian model (BSCt). Evaluation metrics, such as median absolute percentage error (MdAPE) and the percentage of observations within ±20% error (P20), were calculated. External validation using the EWUSH data set showed that SSTA, LR, VancoPK, and BSCt had MdAPE values of 6.4, 10.1, 6.6, and 7.5% and P20 values of 87.1, 82.5, 87.7, and 83.4%, respectively. External validation using the MUSI data set showed that SSTA, LR, and VancoPK had MdAPEs of 5.2, 9.4, and 7.2%, and P20 of 95, 90, and 95%, respectively. Owing to its decent AUC prediction performance, simplicity, and convenience for automated calculation and reporting, SSTA could be used as an adjunctive tool for the AUC-based TDM.
- Open Access
- 13 September 2024
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 45 (1) , 85-89
Interinstitutional Comparison of Vancomycin Area Under the Concentration–Time Curve Estimation in Korea: Need for Standardized Operational Protocols for Therapeutic Drug Monitoring Consultation
Hyun-Ki Kim, M.D., Ph.D., Mikyoung Park, M.D., Ph.D., Jong Do Seo, M.D., Tae-Dong Jeong, M.D., Ph.D., and Misuk Ji, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2024.0218
- 13 September 2024
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 45 (1) , 85-89
Open AccessInterinstitutional Comparison of Vancomycin Area Under the Concentration–Time Curve Estimation in Korea: Need for Standardized Operational Protocols for Therapeutic Drug Monitoring Consultation
Hyun-Ki Kim, M.D., Ph.D., Mikyoung Park, M.D., Ph.D., Jong Do Seo, M.D., Tae-Dong Jeong, M.D., Ph.D., and Misuk Ji, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2024.0218
- Open Access
- 31 January 2024
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (1) , 75-81
Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease
Background/Aims: The achievement of endoscopic remission is an important therapeutic goal in the treatment of inflammatory bowel diseases (IBD). We aimed to evaluate the role of fecal calprotectin (FCP) and ischemia-modified albumin (IMA) as biomarkers for evaluating IBD disease activity.Methods: A total of 48 patients with IBD (20 with ulcerative colitis and 28 with Crohn’s disease) were included in this study. FCP and serum C-reactive protein levels, erythrocyte sedimentation rate, and IMA were measured in patients with IBD and compared with endoscopic findings.Results: Elevated FCP and serum IMA levels were significantly associated with endoscopic non-mucosal healing. The correlation between FCP and IMA was not significant. Analysis of the receiver operating characteristic curve showed that both FCP and IMA had diagnostic value in predicting non-mucosal healing. When the Ln(FCP)+IMA/10 value was calculated using both factors, the predictive value for non-mucosal healing increased; however, no significant difference was observed.Conclusions: IMA could be a candidate serum biomarker for predicting endoscopic mucosal healing in IBD.
- 31 January 2024
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (1) , 75-81
Open AccessIschemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease
Background/Aims: The achievement of endoscopic remission is an important therapeutic goal in the treatment of inflammatory bowel diseases (IBD). We aimed to evaluate the role of fecal calprotectin (FCP) and ischemia-modified albumin (IMA) as biomarkers for evaluating IBD disease activity.Methods: A total of 48 patients with IBD (20 with ulcerative colitis and 28 with Crohn’s disease) were included in this study. FCP and serum C-reactive protein levels, erythrocyte sedimentation rate, and IMA were measured in patients with IBD and compared with endoscopic findings.Results: Elevated FCP and serum IMA levels were significantly associated with endoscopic non-mucosal healing. The correlation between FCP and IMA was not significant. Analysis of the receiver operating characteristic curve showed that both FCP and IMA had diagnostic value in predicting non-mucosal healing. When the Ln(FCP)+IMA/10 value was calculated using both factors, the predictive value for non-mucosal healing increased; however, no significant difference was observed.Conclusions: IMA could be a candidate serum biomarker for predicting endoscopic mucosal healing in IBD.
- Open Access
- 30 June 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (6) , 554-564
Evaluation of Vancomycin Area Under the Concentration–Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment
Hyun-Ki Kim, M.D. and Tae-Dong Jeong, M.D., Ph.D.. Ann Lab Med 2023;43:554-64. https://doi.org/10.3343/alm.2023.43.6.554
- 30 June 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (6) , 554-564
Open AccessEvaluation of Vancomycin Area Under the Concentration–Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment
Hyun-Ki Kim, M.D. and Tae-Dong Jeong, M.D., Ph.D.. Ann Lab Med 2023;43:554-64. https://doi.org/10.3343/alm.2023.43.6.554
- Open Access
- 30 June 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (6) , 628-631
Improving the Work Efficiency of Therapeutic Drug Monitoring Reports Through the Establishment of an Automated Data Transfer System
Seunghoo Lee, M.D., Ph.D., Sangpil Yoon, M.T., Hyun-Ki Kim, M.D., Sollip Kim, M.D., Ph.D., Woochang Lee, M.D., Ph.D., Sail Chun, M.D., Ph.D., and Won-Ki Min, M.D., Ph.D.. Ann Lab Med 2023;43:628-31. https://doi.org/10.3343/alm.2023.43.6.628
- 30 June 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (6) , 628-631
Open AccessImproving the Work Efficiency of Therapeutic Drug Monitoring Reports Through the Establishment of an Automated Data Transfer System
Seunghoo Lee, M.D., Ph.D., Sangpil Yoon, M.T., Hyun-Ki Kim, M.D., Sollip Kim, M.D., Ph.D., Woochang Lee, M.D., Ph.D., Sail Chun, M.D., Ph.D., and Won-Ki Min, M.D., Ph.D.. Ann Lab Med 2023;43:628-31. https://doi.org/10.3343/alm.2023.43.6.628
- Open Access
- 21 April 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (5) , 485-492
Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea
Sang Hyuk Park, M.D., Ph.D., Hyun-Ki Kim, M.D., Joseph Jeong, M.D., Ph.D., Seon-Ho Lee, M.D., Ph.D., Yoo Jin Lee, M.D., Ph.D., Yoo Jin Kim, M.D., Ph.D., Jae-Cheol Jo, M.D., Ph.D., and Ji-Hun Lim, M.D., Ph.D.. Ann Lab Med 2023;43:485-92. https://doi.org/10.3343/alm.2023.43.5.485
- 21 April 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (5) , 485-492
Open AccessPerformance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea
Sang Hyuk Park, M.D., Ph.D., Hyun-Ki Kim, M.D., Joseph Jeong, M.D., Ph.D., Seon-Ho Lee, M.D., Ph.D., Yoo Jin Lee, M.D., Ph.D., Yoo Jin Kim, M.D., Ph.D., Jae-Cheol Jo, M.D., Ph.D., and Ji-Hun Lim, M.D., Ph.D.. Ann Lab Med 2023;43:485-92. https://doi.org/10.3343/alm.2023.43.5.485
- Open Access
- 16 December 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 37 (1)
Association between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
Background: Small dense low‐density lipoprotein (sdLDL) possesses atherogenic potential and is predicted to be susceptible to atherogenic modifications, which further increases its atherogenicity. However, studies on the association between measured or estimated sdLDL cholesterol (sdLDL‐C) levels and atherogenic modification in diverse population groups are lacking.Methods: Surplus serum samples were collected from male subjects with type 2 diabetes mellitus (DM) under treatment (n = 300) and without DM (non‐DM; n = 150). sdLDL and oxidized LDL (oxLDL) levels were measured using the Lipoprint LDL subfractions kit (Quantimetrix Corporation) and the Mercodia oxidized LDL competitive enzyme‐linked immunosorbent assay kit (Mercodia), respectively. The estimated sdLDL‐Cs were calculated from two relevant equations. The effects of sdLDL‐C on oxLDL were assessed using multiple linear regression (MLR) models.Results: The mean (±SD) of measured sdLDL‐C and oxLDL concentrations were 11.8 ± 10.0 mg/dl and 53.4 ± 14.2 U/L in the non‐DM group and 0.20 ± 0.81 mg/dl and 46.0 ± 15.3 U/L in the DM group, respectively. The effects of measured sdLDL‐Cs were significant (p = 0.031), whereas those of estimated sdLDL‐Cs were not (p = 0.060, p = 0.116) in the non‐DM group in the MLR models. The effects of sdLDL‐Cs in the DM group were not significant.Conclusion: In the general population, high level of sdLDL‐C appeared to be associated with high level of oxLDL. The equation for estimating sdLDL‐C developed from a general population should be applied with caution to a special population, such as patients with DM on treatment.
- 16 December 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 37 (1)
Open AccessAssociation between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
Background: Small dense low‐density lipoprotein (sdLDL) possesses atherogenic potential and is predicted to be susceptible to atherogenic modifications, which further increases its atherogenicity. However, studies on the association between measured or estimated sdLDL cholesterol (sdLDL‐C) levels and atherogenic modification in diverse population groups are lacking.Methods: Surplus serum samples were collected from male subjects with type 2 diabetes mellitus (DM) under treatment (n = 300) and without DM (non‐DM; n = 150). sdLDL and oxidized LDL (oxLDL) levels were measured using the Lipoprint LDL subfractions kit (Quantimetrix Corporation) and the Mercodia oxidized LDL competitive enzyme‐linked immunosorbent assay kit (Mercodia), respectively. The estimated sdLDL‐Cs were calculated from two relevant equations. The effects of sdLDL‐C on oxLDL were assessed using multiple linear regression (MLR) models.Results: The mean (±SD) of measured sdLDL‐C and oxLDL concentrations were 11.8 ± 10.0 mg/dl and 53.4 ± 14.2 U/L in the non‐DM group and 0.20 ± 0.81 mg/dl and 46.0 ± 15.3 U/L in the DM group, respectively. The effects of measured sdLDL‐Cs were significant (p = 0.031), whereas those of estimated sdLDL‐Cs were not (p = 0.060, p = 0.116) in the non‐DM group in the MLR models. The effects of sdLDL‐Cs in the DM group were not significant.Conclusion: In the general population, high level of sdLDL‐C appeared to be associated with high level of oxLDL. The equation for estimating sdLDL‐C developed from a general population should be applied with caution to a special population, such as patients with DM on treatment.
- Open Access
- 1 November 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (6) , 621-629
Age Group-specific Reference Intervals for the Elecsys Anti-Müllerian Hormone Assay in Healthy Korean Women: a Nationwide Population-based Study
Misuk Ji , M.D., Ph.D., Kwang-Rae Kim , M.D., Ph.D., Hyun-Ki Kim , M.D., Woochang Lee , M.D., Ph.D., Yeo-Min Yun , M.D., Ph.D., Sail Chun , M.D., Ph.D., and Won-Ki Min , M.D., Ph.D.. Ann Lab Med 2022;42:621-9. https://doi.org/10.3343/alm.2022.42.6.621
- 1 November 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (6) , 621-629
Open AccessAge Group-specific Reference Intervals for the Elecsys Anti-Müllerian Hormone Assay in Healthy Korean Women: a Nationwide Population-based Study
Misuk Ji , M.D., Ph.D., Kwang-Rae Kim , M.D., Ph.D., Hyun-Ki Kim , M.D., Woochang Lee , M.D., Ph.D., Yeo-Min Yun , M.D., Ph.D., Sail Chun , M.D., Ph.D., and Won-Ki Min , M.D., Ph.D.. Ann Lab Med 2022;42:621-9. https://doi.org/10.3343/alm.2022.42.6.621
- Open Access
- 1 May 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (3) , 363-366
Incidence Evaluation of SARS-CoV-2 Variants in the Ulsan Area, Korea, Using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit: A Pilot Study
Sang Hyuk Park, M.D., Ph.D., Hyun-Ki Kim, M.D., Hang Kang, Ph.D., Jung Heon Kim, Ph.D., Jaeseung Lee, M.S., Ji-Hun Lim, M.D., Ph.D., Seon-Ho Lee, M.D., Ph.D., and Joseph Jeong, M.D., Ph.D.. Ann Lab Med 2022;42:363-6. https://doi.org/10.3343/alm.2022.42.3.363
- 1 May 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (3) , 363-366
Open AccessIncidence Evaluation of SARS-CoV-2 Variants in the Ulsan Area, Korea, Using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit: A Pilot Study
Sang Hyuk Park, M.D., Ph.D., Hyun-Ki Kim, M.D., Hang Kang, Ph.D., Jung Heon Kim, Ph.D., Jaeseung Lee, M.S., Ji-Hun Lim, M.D., Ph.D., Seon-Ho Lee, M.D., Ph.D., and Joseph Jeong, M.D., Ph.D.. Ann Lab Med 2022;42:363-6. https://doi.org/10.3343/alm.2022.42.3.363